122 related articles for article (PubMed ID: 2459075)
21. Antiherpes activity of chemically synthesized lipid A-subunit analogue GLA-60 in immunosuppressed mice.
Ikeda S; Tominaga T; Nishimura C; Homma JY; Kiso M; Hasegawa A
Antiviral Res; 1989; 11(4):173-80. PubMed ID: 2545164
[TBL] [Abstract][Full Text] [Related]
22. Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.
Kumazawa Y; Matsuura M; Homma JY; Furuya T; Takimoto H; Inagaki K; Nagumo T; Kiso M; Hasegawa A
Infect Immun; 1989 Jun; 57(6):1845-8. PubMed ID: 2785963
[TBL] [Abstract][Full Text] [Related]
23. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent.
Nagao S; Akagawa KS; Yamada K; Yagawa K; Tokunaga T; Kotani S
Microbiol Immunol; 1990; 34(3):323-35. PubMed ID: 2352499
[TBL] [Abstract][Full Text] [Related]
24. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
25. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
26. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
27. Modulation of natural killer activity by muramyl peptides: relationship with adjuvant and anti-infectious properties.
Le Garrec Y; Morin A
Nat Immun Cell Growth Regul; 1987; 6(2):65-76. PubMed ID: 2439906
[TBL] [Abstract][Full Text] [Related]
28. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
Dewhirst FE
Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
[TBL] [Abstract][Full Text] [Related]
29. Stimulatory effects of muramyl dipeptide and its butyl ester derivative on the proliferation and activation of macrophages in vitro.
Schindler TE; Coffey RG; Hadden JW
Int J Immunopharmacol; 1986; 8(5):487-98. PubMed ID: 3019904
[TBL] [Abstract][Full Text] [Related]
30. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
[TBL] [Abstract][Full Text] [Related]
31. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
Petit C; Monsigny M; Roche AC
J Biol Response Mod; 1990 Feb; 9(1):33-43. PubMed ID: 2319259
[TBL] [Abstract][Full Text] [Related]
32. Marked enhancement of macrophage activation induced by synthetic muramyl dipeptide (MDP) conjugate using monoclonal anti-MDP antibodies.
Leclerc C; Bahr GM; Chedid L
Cell Immunol; 1984 Jul; 86(2):269-77. PubMed ID: 6733783
[TBL] [Abstract][Full Text] [Related]
33. Comparison of murine B cell clonal expansions by synthetic lipid A and muramyl dipeptide analogs.
Saito-Taki T; Nakano M; Kiso M; Hasegawa A
Microbiol Immunol; 1985; 29(11):1111-20. PubMed ID: 2419740
[TBL] [Abstract][Full Text] [Related]
34. Improvement of normothermic rat liver ischemia/reperfusion by muramyl dipeptide.
Cursio R; Gugenheim J; Panaia-Ferrari P; Lasfar A; Tovey M; Chastanet S; Saint-Paul MC; Ferré C; Mouiel J
J Surg Res; 1998 Dec; 80(2):339-44. PubMed ID: 9878335
[TBL] [Abstract][Full Text] [Related]
35. Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets.
Masihi KN; Lange W; Rohde-Schulz B
Cancer Immunol Immunother; 1987; 24(1):19-24. PubMed ID: 3815418
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
Durette PL; Dorn CP; Friedman A; Schlabach A
J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.
Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Watanabe M; Aizawa C; Kiso M; Hasegawa A; Nomoto K
Infect Immun; 1989 Jun; 57(6):1839-44. PubMed ID: 2722242
[TBL] [Abstract][Full Text] [Related]
38. Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.
Kotani S; Takada H; Tsujimoto M; Ogawa T; Mori Y; Sakuta M; Kawasaki A; Inage M; Kusumoto S; Shiba T; Kasai N
Infect Immun; 1983 Aug; 41(2):758-73. PubMed ID: 6409812
[TBL] [Abstract][Full Text] [Related]
39. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
[TBL] [Abstract][Full Text] [Related]
40. Combined effects of synthetic lipid A analogs or bacterial lipopolysaccharide with glucosaminylmuramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Shimizu T; Iwamoto Y; Yanagihara Y; Ikeda K; Achiwa K
Int J Immunopharmacol; 1992 Nov; 14(8):1415-20. PubMed ID: 1464473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
